Skip to content
Health Pets Sleep Hormones About
Health Pets Sleep Hormones About

Latest Research

Sleep

Why Midlife Insomnia Responds Differently to Treatment Than You'd Expect

Researchers found that sleep disruption in women 40-55 follows a distinct hormonal pattern that standard sleep hygiene advice doesn't address.

Dr. Sarah Chen · April 2026 · 4 min
Hormones

The Day-Night Divide: Why Menopause Symptoms Need a Two-Part Approach

A growing body of research shows that daytime and nighttime menopause symptoms operate through different biological pathways.

Dr. Rachel Moore · March 2026 · 5 min
Brain Health

Brain Fog or Something Worse? How to Tell the Difference After 45

Cognitive changes during perimenopause can mimic conditions that frighten women into unnecessary medical testing.

Dr. Lisa Park · March 2026 · 3 min

Blog posts

Title

Title

Date|Author
An excerpt of your blog post's content
Title

Title

Date|Author
An excerpt of your blog post's content
Title

Title

Date|Author
An excerpt of your blog post's content
Title

Title

Date|Author
An excerpt of your blog post's content
Title

Title

Date|Author
An excerpt of your blog post's content
The Health Wire
Evidence-based health information for everyone.
Topics
Menopause Sleep Nutrition
About
About Us Editorial Policy Contact Privacy Policy
© 2026 The Health Wire. All rights reserved. Content is for informational purposes only. The Health Wire does not provide medical advice, diagnosis, or treatment.
Sources referenced: U.S. Food and Drug Administration, “Low Magnesium Levels Can Be Associated With Long-Term Use of Proton Pump Inhibitor Drugs” (Drug Safety Communication, March 2, 2011); National Institutes of Health Office of Dietary Supplements, “Magnesium – Fact Sheet for Health Professionals” (serum magnesium limitations and deficiency risk); Hess, M.W. et al., “Systematic Review: Hypomagnesaemia Induced by Proton Pump Inhibition”, Alimentary Pharmacology & Therapeutics, 2012; Cundy, T. & Dissanayake, A., “Severe Hypomagnesaemia in Long-Term Users of Proton-Pump Inhibitors”, Clinical Endocrinology, 2008; Firoz, M. & Graber, M., “Bioavailability of US Commercial Magnesium Preparations”, Magnesium Research, 2001 (oxide vs citrate absorption); Walker, A.F. et al., “Mg Citrate Found More Bioavailable Than Other Magnesium Preparations in a Randomised, Double-Blind Study”, Magnesium Research, 2003; Ranade, V.V. & Somberg, J.C., “Bioavailability and Pharmacokinetics of Magnesium After Administration of Magnesium Salts to Humans”, American Journal of Therapeutics, 2001; Mayo Clinic consumer health guidance on magnesium forms and magnesium depletion risk in long-term PPI users; American College of Gastroenterology guidance on proton pump inhibitor management and rebound acid hypersecretion; FDA-approved prescribing information and safety labeling for proton pump inhibitors (omeprazole, esomeprazole, pantoprazole, lansoprazole) regarding hypomagnesemia risk.

Search

No products found.